Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 14/20 | 0.49 |
| ▸ | ADORA2A | P29274 | 12/20 | 0.49 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.46 |
| ▸ | CHUK | O15111 | 1/20 | 0.43 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.42 |
| ▸ | GHSR | Q92847 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27612525 | 0.81 | ADORA2A (0.63) | ADORA1ADORA2ACHUKADORA2B | |
| SCHEMBL27631651 | 0.80 | ADORA2A (0.54) | ADORA1ADORA2AHRH3CHUKADORA2B | |
| SCHEMBL27612570 | 0.80 | MAPT (0.53) | ADORA1ADORA2A | |
| SCHEMBL27612778 | 0.80 | ADORA1 (0.44) | ADORA1ADORA2ACHUKGHSR | |
| Hydrochloric Acid SCHEMBL28757234 | 0.79 | MAPT (0.51) | ADORA1ADORA2A | |
| SCHEMBL27612872 | 0.77 | PIK3CG (0.56) | ADORA1ADORA2ACHUK | |
| SCHEMBL27631713 | 0.77 | ADORA2A (0.51) | ADORA1ADORA2AHRH3ADORA2B | |
| SCHEMBL4407006 | 0.77 | NPC1 (0.50) | ADORA1ADORA2AHRH3ADORA2B | |
| SCHEMBL27612323 | 0.77 | CSNK1A1 (0.55) | ADORA1ADORA2AADORA2B | |
| SCHEMBL27716588 | 0.75 | CSNK1A1 (0.53) | ADORA1ADORA2AADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1678321-A | Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds | RIGEL PHARMACEUTICALS INC (US) | 2005-10-05 | — | — | CN | disclosed |